SC 13D/AAMENDMENTALLOCIK 0001737287

Allogene Therapeutics, Inc.

Name: SEC EDGAR filing 0001999371-26-021654
Creator: Allogene Therapeutics, Inc.
License: https://www.usa.gov/government-works

5%+ activist stake (SC 13D/A) filed September 30, 2026.

Disclosure of beneficial ownership above 5% with intent to influence company control.

Open the filing on SEC.gov

New to the SC 13D/A? What it is and how to read one

Filing facts

Accession number: 0001999371-26-021654
Filer: Allogene Therapeutics, Inc.
Ticker: ALLO
CIK: 0001737287
Form type: SC 13D/A
Form description: 5%+ activist stake
Filed at: September 30, 2026
Industry: SIC 2836Biological Products
Last verified: October 1, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1737287/000199937126021654/0001999371-26-021654-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Allogene Therapeutics, Inc. (0001737287) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001999371-26-021654.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.